United Kingdom

Kyorin Holdings Inc (4569.T)

4569.T on Tokyo Stock Exchange

23 Mar 2018
Change (% chg)

¥-64 (-3.10%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Kyorin Holdings says integration of production function
Tuesday, 19 Dec 2017 

Dec 19(Reuters) - Kyorin Holdings Inc <4569.T>:Says its Tokyo-based drug unit, which was established in October, will take over Noshiro plant of unit Kyorin Pharmaceutical Company, Limited and manufacture division of KYORIN Rimedio Co.,Ltd., effective April 1, 2018.Says the Tokyo-based drug unit will merge with the company's Shiga-based unit KYORIN Pharmaceutical Facilities Co.,Ltd, effective April 1, 2018.Says KYORIN Pharmaceutical Facilities Co.,Ltd will be dissolved after the merger .  Full Article

Kyorin Holdings unit signs production and marketing license agreement with vietnamese pharmaceutical company
Wednesday, 22 Nov 2017 

Nov 22(Reuters) - Kyorin Holdings Inc <4569.T>:Says its subsidiary KYORIN Rimedio Co., Ltd. has agreed to provide a production and marketing license for generic medicine to BinhDinh Pharmaceutical and Medical Equipment JSC.Says pursuant to the terms of the license agreement, KYORIN Rimedio will license the production rights for Losarhyd Combination Tablets LD and two other products to BIDIPHAR in return for a one-time lump sum payment upon conclusion of the agreement and KYORIN Rimedio will also receive royalties.  Full Article

KYORIN Holdings unit grants MSD K.K. manufacturing and marketing rights for medicine of allergic diseases
Wednesday, 28 Sep 2016 

KYORIN Holdings Inc <4569.T>:Says MSD K.K. received a manufacturing and marketing approval for DESALEX® Tablets 5mg for the treatment of allergic diseases from the co's unit KYORIN Pharmaceutical Co., Ltd..  Full Article

Kaken Pharmaceutical to co-promote allergic medicine with Kyorin Holdings unit
Monday, 11 Jul 2016 

Kaken Pharmaceutical Co Ltd <4521.T>:Says the company entered into basic agreement with Kyorin Holdings Inc <4569.T>'s unit on co-promotion of an allergic medicine, whose exclusive sales right is owned by the Kyorin Holdings's unit.  Full Article

KYORIN Holdings unit to sign exclusive distribution agreement
Wednesday, 25 May 2016 

KYORIN Holdings Inc <4569.T>:Says company MSD to grant subsidiary KYORIN Pharmaceutical an exclusive distribution license for an allergic disease treatment drug in Japan changed from joint marketing.  Full Article

BRIEF-R&I affirms Kyorin Holdings rating at "A-" and says stable outlook -R&I

* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I